万维提示：
1、投稿方式：在线投稿。
2、官网网址：https://onlinelibrary.wiley.com/journal/16000536
3、投稿网址：http://mc.manuscriptcentral.com/cod
4、官网邮箱：codedoffice@wiley.com（编辑部）
5、期刊刊期：月刊，一个月出版一期。
2021年5月6星期四
投稿须知
【官网信息】
Author Guidelines
4. PREPARING THE SUBMISSION
File Types
Manuscripts must be submitted as Word (DOC[X]) or LaTex (TEX+BIB) files, and figures submitted as high resolution JPEG or PNG files, or as vector graphic PDFs. Do not embed figures within the main text; append them as separate files.
Cover Letters
Cover letters are not mandatory; however, they may be supplied at the author’s discretion.
Parts of the Manuscript
The manuscript should be submitted in separate (doc, docx, tex+bib) files: main text file; figures.
Main Text File
The text file should be presented in the following order (please note that supplying this information only in the Scholar One metadata is not sufficient; the items listed below must be included in the actual manuscript text):
i. A short informative title that contains the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. The full names of the authors: first name given in full, additional first names as initial, family name(s) underlined;
iii. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
iv. Acknowledgments;
v. Abstract and keywords;
vi. Main text;
vii. References;
viii. Tables (each table complete with title and footnotes);
ix. Figure legends;
x. Appendices (if relevant, e.g. online supplemental information).
Figures and supporting information should be supplied as separate files.
Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Author Contributions: For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.
Acknowledgments
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section.
If the authors submit in the name of a research group, whose further members have contributed data, these can be separately acknowledged as “collaborators”, both in the manuscript and in the metadata entered in Scholar One. "Collaborators" information should be the same as for authors, ie., include first and family name (the latter NOT underlined here), Institution, City, Country. Please note that the name of the group should, in this case, appear after the authors, and, identically, in the header of the acknowledgement footnote. In addition to collaborator names, their institution and address should be entered, as with authors proper. This enables transfer of the set of collaborators in Medline, where they can be retrieved. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Abstract
In addition to the abstract (see above for requirements related to different publication categories), please provide 3-8 keywords. Keywords should be taken from those listed in the Scholar One submission system, supplemented with appropriate terms, e.g. including CAS numbers.
Main Text
1. Introduction - Present the background briefly, but do not review the subject extensively. Give only pertinent, current (if possible) references. State the specific questions you want to answer.
2. Patients, Methods/Materials or Methods - Describe selection of patients or experimental animals, including controls. Do not use patients' names or hospital numbers.
- Identify patch test materials (supplier, dilution, vehicle), chambers used, application period and days of readings (use D2, D4 not 48, 96hrs etc).
- Identify methods, apparatus (manufacturer's name and address; for US companies, please include spelled-out state, but do not add "U.S.A.") and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations.
- Identify drugs, chemicals and consumer products (including cosmetics unless a specific reason for non-disclosure is given) including generic name, dosage and route(s) of administration. Do not use ‘trademark’ and ‘registered’ symbols.
- Indicate whether the procedures were approved by a properly constituted Ethics Committee in your country, or in accordance with the current Helsinki Declaration. Drug trials must be logged on a public register, the register and the registration number must be stated in the text.
3. Results - Present results in logical sequence in tables and illustrations. In the text, explain, emphasise or summarise the most important observations. When appropriate, data should be statistically evaluated and the appropriateness of the statistical methodology explained. Estimates (proportions, means, risk quotients etc.) should include confidence intervals. Authors are encouraged to seek advice from a statistician.
4. Discussion - Do not repeat in detail data given in the Results section. Emphasise the new and important aspects of the study. Relate the observations to other relevant studies. On the basis of your findings (and those of others), discuss possible implications/conclusions. Limitations, as well as strengths, of your study should be discussed, however, avoiding sweeping generalisations. When stating a new hypothesis, clearly identify it as such.
Patient Photo Permissions
If photographs are recognizable, the authors must attest that they have obtained written consent for permission to publish.
References
All references should be numbered consecutively in order of appearance. In text citations should cite references in consecutive order using Arabic superscript numerals.
For more information about this reference style, please see the AMA Manual of Style.
Reference examples follow; list up to 6 authors, while, if more than 6, list the first 3 followed by "et al".
Journal article
1. Malmberg P, Guttenberg T, Ericson MB, Hagvall L. Imaging mass spectrometry for novel insights into contact allergy - a proof-of-concept study on nickel. Contact Dermatitis. 2018;78(2):109-116.
Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.
Internet Document
3. American Cancer Society. Cancer Facts & Figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf. Accessed March 3, 2003.
If using tools for reference management and formatting, we recommend the JAMA or JAMA dermatology output style as a good match for Contact Dermatitis
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, or be included in the main text, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figure Legends
Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Figures (illustrations, chemical structures and photographs)
Should clarify the text and their numbers be kept to a minimum. Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Colour Figures. Figures submitted in colour may be reproduced in colour free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white or grey-scales so that they are legible if printed in black and white.
Data Citation
Please review Wiley’s data citation policy here.
Additional Files
Appendices
Appendices which shall appear as part of the actual publication (i.e., not as online-only ‘supporting information’, see below) will be published after the references. For submission they should be supplied as separate files but referred to in the text.
Graphical Abstract
Authors are invited to submit a Graphical Abstract (GA). The GA will be shown on Wiley Online Library as an addition to usual content and are intended to increase visibility and promote attention concerning the article. The GA should summarize the main findings of the article in an illustrative design and must include two or three highlights – each 30 words or fewer – summarising the key findings presented in the paper, as well as a figure that best represents the scope of the paper. Arial 12p should be used as the font for both text and figure. The GA should contain a title of maximum 6 words which should stay above the highlights. The background should be white. A 9:6 ‘landscape’ orientation should be used for the figure, which should normally not repeat a figure used in the main article. Ideally, the figure should be eye-catching and focus on the main finding of the study, or summarise the study’s major findings, and be mostly self-explanatory. Any text incorporated in the figure should be kept to a minimum. The final GA together with its highlights should be interpreted as stand-alone image, without any typical legend. If needed, abbreviations should be listed at the bottom of the highlights, with open names.
Please upload your highlights as an editable MS Word file. The image should be supplied as a TIF, EPS or PDF file and should not exceed 1 MB. Graphical Abstract entries must be submitted to ScholarOne as distinct document types:
a 'Graphical Abstract', with the file name ‘GA_FirstAuthor’sFamilyName_ManuscriptNumber’ and
Highlights should be uploaded as 'Graphical Abstract Highlights' with the title ‘Highlights_FirstAuthor’sFamilyName_ManuscriptNumber’
during the revised manuscript submission process.
Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.
Click here for Wiley’s FAQs on supporting information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following points provide general advice on formatting and style.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/L); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils). Do not use Roman numerals in the text, except where established (e.g., “fragrance mix II”).
Decimal fractions: a decimal point, and not a comma, must be used. The minus sign is shown as --. Use a protected space between digits to separate thousands (e.g. million: 1 000 000). Confidence Intervals should be in the format 95%CI: 1.23-4.56 unless there is a negative value, in which case 95%CI: -1.23 to 4.56 or, 95%CI: -4.56 to -1.23. Please round %, RR, OR etc. to 1 decimal place or 2 significant figures, as appropriate, and give P-values with 2 significant figures; if P < .001, write P < .001 (P for P-value all in uppercase italics).
Chemical names and botanical extracts should be INCI, if available (http://ec.europa.eu/consumers/cosmetics/cosing/), and in preference to other common names; CAS numbers should be provided, if appropriate (e.g., 2-bromo-2-nitropropane-1,3-diol [bronopol; CAS no. 52-51-7]). For drugs, the International Non-proprietary Name (INN) should be used. (http://www.who.int/medicines/services/inn/en/).
Chemical structures should be produced with a chemical structure drawing program (e.g., ChemSketch) and conform to the American Chemical Society settings.
English Language Requirements: Authors for whom English is a second language may choose to have their manuscript professionally edited before submission. We are unable to accept any Manuscript submitted in inaccessible English or in a form unsuitable for effective peer review (http://authorservices.wiley.com/bauthor/english_language.asp).
Resource Identification Initiative
The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.
To Obtain Research Resource Identifiers (RRIDs)
Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
Search for the research resource (please see the section titled “Search Features and Tips” for more information).
Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.
If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact rii-help@scicrunch.org for assistance.
Example Citations
Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"
Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"
Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"
Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"
Submission of revisions
If as outcome of the review process a revision is recommended, the revised manuscript should normally be submitted by the authors within 6 weeks. It is mandatory that all changes to the original manuscript (deletions, insertions, corrections) are highlighted, e.g. by using the 'track changes' function of the word processor. A separate point-by-point reply to reviewers' comments is encouraged, but not a substitute for above. Re-submissions not complying with this requirement will be immediately returned to the author.
Wiley Author Resources
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Wiley's policy on the confidentiality of the review process is available here.
Human Studies and Subjects
For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.
Patient anonymity should be preserved. When detailed descriptions, photographs, or videos of faces or identifiable body parts are used that may allow identification, authors should obtain the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use. Where photographs are used they need to be cropped sufficiently to prevent human subjects being recognized; black eye bars should not be used as they do not sufficiently protect an individual’s identity; they are not a substitute for above-mentioned consent).
Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:
• US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
• UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
• European authors outside the UK should conform to Directive 2010/63/EU.
Clinical Trial Registration
The journal requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.
……
